Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial
卡培他滨联合贝伐珠单抗(有或无阿特珠单抗)治疗难治性转移性结直肠癌的疗效评估:一项随机临床试验
期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2021.49040
Mettu, Niharika B; Ou, Fang-Shu; Zemla, Tyler J; Halfdanarson, Thorvardur R; Lenz, Heinz-Josef; Breakstone, Rimini A; Boland, Patrick M; Crysler, Oxana V; Wu, Christina; Nixon, Andrew B; Bolch, Emily; Niedzwiecki, Donna; Elsing, Alicia; Hurwitz, Herbert I; Fakih, Marwan G; Bekaii-Saab, Tanios